Recommendations and unanswered questions in the diagnosis and treatment of thyroid nodules. Report of the Thyroid Section of the German Society of Endocrinology;Empfehlungen und offene fragen in der diagnostik und therapie von schilddrüsenknoten. Stellungnahme der Sektion Schilddrüse der Deutschen Gesellschaft für Endokrinologie

Deutsche Medizinische Wochenschrift

Volumn 130, Issue 31-32, 2005, Pages 1831-1836

  Paschke, Ralf ^a   Reiners, C ^b   Fuhrer D ^a   Schmid, K W ^c   Dralle, H ^d   Brabant, G ^e  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; LIOTHYRONINE; RADIOACTIVE IODINE; THYROTROPIN; THYROXINE;

ASPIRATION CYTOLOGY; AUTOSOMAL DOMINANT DISORDER; COWDEN SYNDROME; DIAGNOSTIC IMAGING; DOPPLER ECHOGRAPHY; GERMANY; HUMAN; HYPERTHYROIDISM; LABORATORY TEST; ORGANIZATION; PRACTICE GUIDELINE; REVIEW; THYROID DISEASE; THYROID HORMONE BLOOD LEVEL; THYROID MEDULLARY CARCINOMA; THYROID NODULE; THYROID SCINTISCANNING;

EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; THYROID NODULE;

EID: 23844491837     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-871906     Document Type: Review

References (50)

1. Bennedbaek FN, Perrild H, Hegedüs L. Diagnosis and treatment of the solitary thyroid nodule. Results of a European survey. Clin Endocrinol 2000; 50: 357-363
2. Bennedbaek FN, Hegedüs L. Management of the solitary thyroid nodules: results of a North American Survey. J Clin Endocrinol Metab 2000; 85: 2493-2498
3. Belfiore A, La Rosa GL, La Porta GA et al. Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med 1992; 93: 363-369
4. Belfiore A, La Rosa G, Padova G, Sava L, Ippolito O, Vigneri R. The frequency of cold thyroid nodules and thyroid malignancies in patients from an iodine-deficient area. Cancer 1987; 60: 3096-3102
5. Brauer VFH, Paschke R. Pathophysiologische Grundlagen der Prävention und medikamentösen Therapie von euthyreoten Schilddrüsenknoten. Dtsch Med Wochenschr 2003; 128: 2324-2328
6. Brauer VFH, Hentschel B, Paschke R. Therapieziele; Resultate und Perspektiven der medikamentösen Therapie von euthyreoten Schilddrüsenknoten. Dtsch Med Wochenschr 2003; 128: 2381-2387
7. Bonnema SJ, Bennedbaek FN, Wiersinga WM et al. Management of the nontoxic multinodular goitre: a European questionnaire study. Clin Endocrinol 2000; 53: 5-12
8. Ceccarelli, Bencivelli W, Vitti P, Grasso L, Pinchera A. Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20 years' retrospective study. Clin Endocrinol 2005; 62: 331-335
9. Dietlein M, Dressier J, Grunwald F, Joseph K, Leisner B, Moser E, Reiners C, Rendl J, Schicha H, Schneider P, Schober O Deutsche Gesellschaft fur Nuklearmedizin. Guideline for in vivo- and in vitro procedures for thyroid diseases (version 2). Nuklearmedizin 2003; 42: 109-115
10. Dietlein M, Dressier J, Eschner W, Leisner B, Reiners C, Schicha H Deutsche Gesellschaft für Nuklearmedizin, Deutsche Gesellschaft für Medizinische Physik. Procedure Guideline for Thyroid Scintigraphy (Version 2). Nuklearmedizin 2003; 42: 120-122
11. Dietlein M, Dressler J, Grünwald F, Leisner B, Moser E, Reiners C, Schicha H, Schneider P, Schober O Deutsche Gesellschaft für Nuklearmedizin. Guideline for Radioiodine Therapy for Benign Thyroid Diseases (Version 3). Nuklearmedizin 2004; 43: 217-220
12. Dietlein M, Moka D, Dederichs B, Hunsch E, Lauterbach KW, Schicha H. Kosten-Effektivitäts-Analyse: Radioiod oderthyreostatische Medikation bei der Primärbehandlung der Immunhyperthyreose. Nuklearmedizin 1999; 38: 7-14
13. Ferrari C, Reschini E, Paracchi A. Treatment of the autonomous thyroid nodule: a review. Eur J Endocrinol 1996; 135: 383-390
14. Franklyn JA. Commentary: Lack of consensus in Europe in the management of nontoxic multinodular goitre. Clin Endocrinol 2000; 53: 3-4
15. Gharib H. Changing concepts in the diagnosis and management of thyroid nodules. Endocrinol Metab Clin North Am 1997; 26: 777-800
16. Hampel R, Kulberg T, Klein K et al. Goiter incidence in Germany is greater than previously suspected. Med Klin 1995; 90: 324-329
17. Hegedus L, Bonnema SJ, Bennedbaek FN. Management of simple nodular goiter: current status and future perspectives. Endocr Rev 2003; 24: 102-132
18. Hermus AR, Huysmans DA. Treatment of benign nodular thyroid disease. N Engl J Med 1998; 338: 1438-1447
19. Holm LE, Ludell G, Israelsson A, Dahlqvist I. Incidence of Hypothyroidism Occurring After Iodine-131 Therapy for Hyperthyroidism. J Nuclear Med 1982; 23: 103-107
20. "Informationen zur genetischen Beratung und Einverstä ndniserklärung", "Leitlinien zu genetische Beratung"; http://www.bv-medgen.de/welcome.html)
21. Kahaly GJ, Dietlein M. Cost estimation of thyroid disorders in Germany. Thyroid 2002; 12: 909-914
22. Karges W, Dralle H, Raue F, Mann K, Reiners C, Grussendorf M, Hufner M, Niederle B, Brabant G. Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: german evidence-based consensus recommendation. Exp Clin Endocrinol Diabetes 2004; 112: 52-58
23. Klein E, Kracht J, Krüskemper H-L, Reinwein D, Scriba PC. Praxis der Schilddrüsendiagnostik. Dtsch Med Wochenschr 1973; 98: 2362-2370
24. Knudsen N, Laurberg P, Perrild H, Bulow I, Ovesen L, Jorgensen T. Risk factors for goiter and thyroid nodules. Thyroid 2002; 12: 879-888
25. Krohn K, Führer D, Bayer Y, Eszlinger M, Brauer V, Neumann S, Paschke R. Etiolgy of euthyroid and toxic multinodular goiter. Endocrine Reviews 2005; 26: 504-524
26. Leenhardt L, Hejblum G, Franc B, Fediaevsky LP, Delbot T, Guillouzic D, Ménégaux F, Guillausseau C, Hoang C, Turpin G, Aurengo A. Indications and Limits of Ultrasound-Guided Cytology in the Management of Nonpalpable Thyriod Nodules. J Clin Endocrinol Metabolism 1999; 84: 24-28
27. Mazzaferri EL. Thyroid cancer in thyroid nodules: finding a needle in the haystack. Am J Med 1992; 93: 359-362
28. Mazzaferri EL Management of a solitary thyroid nodule. N Engl J Med 1993; 328: 553-559
29. Mazzaferri EL, Robbins RJ, Spencer CA, Braverman LE, Pacini F, Wartofsky L, Haugen BR, Sherman SI, Cooper DS, Braunstein GD, Lee S, Davies TF, Arafah BM, Ladenson PW, Pinchera A. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 2003; 88: 1433-1441
30. Merchant SH, Izquierdo R, Khurana K. Is repeated fine-needel aspiration cytology useful in the management of patients with benign nodular thyroid disease. Thyroid 2000; 10: 489-492
31. Miccoli P, Berti P, Materazzi G, Minuto M, Barellini L. Minimally invasive video-assisted thyroidectomy: five years of experience. J Am Coll Surg 2004; 199: 243-248
32. Miehle K, Paschke R. Therapy of hyperthyroidism. Exp Clin Endocrinol Diabetes 2003; 111: 305-318
33. Moser E, Pickardt CR, Mann K, Engelhardt D, Kirsch CM, Knesewitsch P, Tatsch K, Kreisig T, Kurz C, Saller B. Ergebnisse der Radiojod-Behandlung von Patienten mit immunogener und nicht immunogener Hyperthyreose bei Anwendung unterschiedlicher Herddosen. Nuklearmedizin 1988; 27: 98-104
34. Oertel YC. A pathologist trying to help endocrinologists to interpret cytopathology reports from thyroid aspirates. J Clin Endocrinol Metab 2002; 87: 1459-1461
35. Ortiz R, Hupart KH, Defesi CR et al. Effect of early referral to an endocrinologist on efficiacy and cost of evaluation and development of treatment plans in patients with thyroid nodules. J Clin Endocrinol Metab 1998; 83: 3803-3807
36. Papini E, Guglielmi R, Bianchini A, Crescenzi A, Taccagna S, Nardi F, Panunzi C, Rinaldi R, Toscano V, Pacella CM. Risk of Malignancy in Nonpalpable Thyroid Nodules: Predictive Value of Ultrasound and Color-Doppler Features. J Clin Endocrinol Metab 2002; 87: 1941-1946
37. Reiners C, Schneider P. Radioiodine therapy of thyroid autonomy. Eur J Nucl Med 2002; 43: 471-478
38. Reiners C, Wegscheider K, Schicha H, Theissen P, Vaupel R, Wrbitzky R, Schumm-Dräger P-M. Prevalence of thyroid disorders in the working population of Germany: Ultrasonography screening in 96,278 unselected employees. Thyroid 2004; 14: 926-932
39. Reiners C, Geling M, Luster M, Farahati J, Mäder U. Epidemiologie des Schilddrüsenkarzinoms. Onkologe 2005; 11: 11-19
40. Rojeski MT, Gharib H. Nodular thyroid diesase. Evaluation and management. N Engl J Med 1985; 313: 428-436
41. Ross DS. Editorial: Nonpalpable Thyroid Nodules-Managing an Epidemic. J Clin Endocrinol Metabolism 2002; 87: 1938-1940
42. Sailer B, Esser I, Horn K et al. Diagnostik und Therapie von Schilddrüsenkrankheiten. Internist 1997; 38: 177-185
43. Singer A, Cooper DS, Daniels GH et al. Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. Arch Intern Med 1996; 156: 2165-2172
44. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, Gorman Cooper RS, Weissman NJ. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004; 14: 228-238
45. Thomusch O, Machens A, Matuschka C, Dralle H. Cost analysis of surgical procedures for toxic nodular goiter. Exp Clin Endocrinol Diab 1998; 106: 71-73
46. Vidal-Trecan GM, Stahl JE, Durand-Zaleski I. Managing toxic thyroid adenoma: a cost-effectiveness analysis. Eur J Endocrinol 2002; 146: 283-294
47. Volzke H, Ludemann J, Robinson DM, Spieker KW, Schwahn C, Kramer A, John U, Meng W. The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area. Thyroid 2003; 13: 803-810
48. Völzke H, Alte D, Kohlmann T, Lüdemann J, Nauck M, John U, Meng W. Reference intervals of serum thyroid function tests in a previously iodine-deficient area. Thyroid 2005; 15: 279
49. Wesche MF, Tiel V, Buul MM, Lips P, Smits NJ, Wiersinga WM. A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter. J Clin Endocrinol Metab 2001; 86: 998-1005
50. Wiersinga WM. Is repeated fine-needle aspiration cytology indicated in (benign) thyroid nodules? EurJ Endocrinol 1995; 132: 661-662